Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial: chronic myelogenous leukemia - Flygt, Hjalmar; Söderlund, Stina; Richter, Johan; Saußele, Susanne; Koskenvesa, Perttu; Stenke, Leif; Mustjoki, Satu; Dimitrijevic, Andreja; Stentoft, Jesper; Majeed, Waleed; Roy, Lydia; Wolf, Dominik; et al. (Leukemia, 2024)
Online veröffentlicht: 26. Januar 2024